[Clinical experimentation with a new hypoglycemic agent (glipizide)].
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001786:Blood Glucose; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D003510:Cyclohexanes / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004361:Drug Tolerance; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D001786:Blood Glucose; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D011719:Pyrazines; D013453:Sulfonylurea Compounds; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase
Sperimentazione clinica di un nuovo farmaco ipoglicemizzante (glipizide.